Xilio Therapeutics
Latest round
- Series C
Last raised
- Feb 2021
Total raised
- $233M
Investors
- 14
About Xilio Therapeutics
Established in 2016 and based in Massachusetts, US, Xilio Therapeutics, Inc. is a biopharmaceutical company that develops immunotherapeutic products and tumor-selective therapies that overcome toxicities associated with validated IO therapies. The company was founded by Rene Russo (CEO). In October 2021, the company got listed on Nasdaq Global Select Market under the ticker symbol XLO. Xilio Therapeutics focuses on enhancing the lives of cancer patients by utilizing the immune system to create deep and long-lasting clinical responses. The company's line of products includes XTX202 (Tumor-selective IL-2 agonist), XTX301 (Tumor-selective IL-12), XTX401 (Tumor-selective IL-15), and XTX101 (Tumor-selective anti-CTLA-4 antibody). Xilio Therapeutics, Inc. plans to use the funds to advance XTX202 and XTX101 into clinical development.
Who invested in Xilio Therapeutics
14 investors across 4 rounds
See all investors in Xilio Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Xilio Therapeutics
Who invested in Xilio Therapeutics?
Xilio Therapeutics has 14 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Xilio Therapeutics raised?
Xilio Therapeutics has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did Xilio Therapeutics last raise money?
Xilio Therapeutics's most recent round on record is a Series C, in Feb 2021.
What does Xilio Therapeutics do?
Established in 2016 and based in Massachusetts, US, Xilio Therapeutics, Inc.
Where is Xilio Therapeutics headquartered?
Xilio Therapeutics is headquartered in Waltham, US.
Which VCs invest in companies like Xilio Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Xilio Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like Xilio Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.